Outcome of Tuberculosis Control Program in Red Sea State, Sudan
American Journal of Internal Medicine
Volume 5, Issue 5, September 2017, Pages: 79-82
Received: Mar. 2, 2017; Accepted: Mar. 23, 2017; Published: Oct. 23, 2017
Views 1683      Downloads 81
Authors
Bashir Abdrhman Bashir, Medical Laboratory Sciences Division, Port Sudan Ahlia College, Port Sudan, Sudan
Yousif Mohammed Saeed, Consultant Chest Physician, Port Sudan Teaching Hospital, Port Sudan, Sudan
Article Tools
Follow on us
Abstract
Tuberculosis (TB) is an endemic disease in Red Sea State. Efforts to control this disease started in 1996 with the establishment of a national tuberculosis control committee. Field application of a national tuberculosis program (NTP) was implemented in Port Sudan by the ministry of health, according to the guidelines of the WHO. A retrospective cross-sectional study was conducted to evaluate the outcome of tuberculosis control after the application of this program since 2002 to 2010. The active TB cases admitted and treated in Red Sea tuberculosis diagnostic center were studied. The outcome of control was evaluated, and comparison was made between the years 2002 to 2010. 12506 subjects were enrolled in this study. 8337 (66.7%) were males and 4169 (33.3%) were females. The ages ranged between 14 – 76 years. The total number of TB cases were decreased by 61% (from 1803 in 2002 to 1100 in 2010). The total Pulmonary TB (PTB) positive cases were reduced from 579 (32%) cases in 2002 to 240 (22%) cases in 2010. Default rate decreased in 2002 (11.9%) and increased in 2010 (16.7%). However, there was no substantial improvement in the cure rate, but inversely increased the default rate and death rate (16.7% and 9.6% respectively). The study demonstrated a positive correlation of mortality rate with the default rate (P< 0.023). Accordingly, the overall outcome of the application of the NTP was relatively satisfactory. A recommendation for speedy improve the infrastructure accompanied by supporting material of the health care system to create a suitable successful program is essential.
Keywords
Tuberculosis, Outcome, Red Sea State, TB Control, Sudan
To cite this article
Bashir Abdrhman Bashir, Yousif Mohammed Saeed, Outcome of Tuberculosis Control Program in Red Sea State, Sudan, American Journal of Internal Medicine. Vol. 5, No. 5, 2017, pp. 79-82. doi: 10.11648/j.ajim.20170505.13
Copyright
Copyright © 2017 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
[1]
World Health Organization. World health reports the global tuberculosis epidemic. 2001; 233, P 1 – 2.
[2]
The World Factbook. [https://www.cia.gov/library/publications/the world-factbook/index.html].
[3]
Lewis MP, ed: Ethnologue: Languages of the World. Dallas, Texas SIL International; Sixteenth 2009.
[4]
World Development Indicators database. [http://ddpext.worldbank.org/ext/ddpreports/ViewSharedReport? &CF=&REPORT_ID=9147&REQUEST_TYPE=VIEWADVANCED].
[5]
El-Sony AI, Khamis AH, Enarson DA, Baraka O, Mustafa SA, Bjune G: Treatment results of DOTS in 1797 Sudanese tuberculosis patients with or without HIV co-infection. Int J Tuberc Lung Dis 2002, 6 (12): 1058-1066.
[6]
Stabler JM, Nicod L, Janssens JP, Extra pulmonary tuberculosis. Rev Mal Respir. 2012; 29 (4): 566 – 78.
[7]
World Health Organization: Global tuberculosis control: WHO Report 2010. Geneva; 2010.
[8]
Abdallah TM, Ali AA. Epidemiology of tuberculosis in eastern Sudan. Asian Pac J Trop Biomed. 2012; 2 (2): 999 – 1001.
[9]
Ali AA, Abdallah TM. Clinical presentation and epidemiology of female genital tuberculosis in eastern Sudanese. Int J Gyaencol Obstet. 2012; 1119 (3): 236 – 238.
[10]
WHO Tuberculosis Programme. Framework for effective tuberculosis control. Genva, Switzerland: World Health Organization, 1994. World Health Organization Publication WHO/TB/94.179.
[11]
El-Sony AI: The cost to health services of human immunodeficiency virus (HIV) co-infection among tuberculosis patients in Sudan. Health Policy. 2006, 75 (3): 272-279.
[12]
World Health Organization. Treatment of Tuberculosis: guideline. 4< sup>th edition, WHO/HTM/TB/.2009. 420. 9789241547833.
[13]
Horsbergh CR, Barry CE, Lange C. Treatment of Tuberculosis. N Engl J Med, 2015; 373: 2149 – 60.
[14]
Castelnuovo B. A review of Compliance to anti-tuberculosis treatment and risk factor for defaulting treatment in sub Saharan Africa. African Health Sciences. 2010; 10 (4): 320 – 323.
[15]
Jin J, Sklar GE, Oh VM, Li SC. Factor affecting therapeutic compliance: A review from the patient’s perspective. The Clin Risk Manag. 2008; 4 (1): 269 – 86.
[16]
Al-Hajoj S, Varghese B, Shookri MM, Al-omari R et al. epidemiology of antituberculosis drug resistance in Saudi arabia: finding of the first national survey. Antimicrob Agents Chemother. 2013; 57 (5): 2161 – 66.
[17]
Vijay S, Balasangameswara VH, Jagannatha PS, Saroja VN et al. Defaults among Tuberculosis patients treated Under DOTS in Bangalore city: A search for solution. Int. J Tub. 2003; 50: 185 – 95.
[18]
Thaim S, Lefevre AM, Hane F et al. Effectiveness of a stategy to improve Adherence to Tuberculosis Treatment in a Resource-Poor seting. JAMA. 2007; 297 (4): 367 – 379.
[19]
Karumbi J, Garner P. Directly observed therapy for treating tuberculosis. Cochrane Database of systemic Reviews. 2015; issue 5 Art. No.: CD 003343.
[20]
Moonan PK, Quitagua T, Pogoda J, Woo G et al. Does directly observed therapy (DOT) reduced drug resistance tuberculosis? BMC Public Health. 2011; 11: 19.
[21]
De Queiroz EM, Guanito MC, Ferreira KR, Bertolozzi MR. Tuberculosis: limitations and strengths of directly observed treatment short-course. Rev. Latino Enfermagem, 2012; 20 (2): 369 – 77.
[22]
Ntshanga SP, Rustomijee R, Mabaso M. Evaluation of Directly Observed Therapy for tuberculosis in Kwazulu-Natal, South Africa. Trans R Soc Trop Med Hyg. 2009; 103 (6): 571 – 4.
[23]
Result of directly observed short-course chemotherapy in 112,842 Chinese patients with smear-positive tuberculosis. China tuberculosis control collaboration. Lancet, 1996; 347: 358 – 62.
[24]
Meulemans H, Martelmans D, Liefooghe R, Mertens P et al. the limit to patient compliance with directly observed therapy for tuberculosis: a scocio-medical study in Pakistan. Int J Health Plann Mgmt. 2002; 17: 249 – 267.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186